At a glance
- Originator Unknown
- Developer Istituto Biochimico Italiano G Lorenzini
- Class Antiplatelets; Antiulcers; Cyclohexanes; Gastric antisecretories; Prostaglandins; Small molecules
- Mechanism of Action Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 03 Jun 1997 No-Development-Reported for Thrombosis in Italy (Unknown route)